What type of study is this?

This is a Animal Study study (also classified as: Quantitative Study).

September 27, 2025PLoS ONEOpen Access

Investigation of phytochemical and biochemical attributes of hypoglycemic activity of Atriplex crassifolia (C.A. Mey) extracts in alloxan diabetic animal model

View Full Paper

Ask AI

Bookmark

Authors

Assessment finds Atriplex crassifolia extracts lower blood glucose levels in diabetic rats, suggesting their potential therapeutic role.

Atriplex crassifolia extracts significantly reduced blood glucose levels in an alloxan-induced diabetic model.
Key extracts, ACEA and ACNB, demonstrated notable hypoglycemic effects during oral glucose tolerance tests.
The study employed various doses to evaluate the extracts' effectiveness over a 28-day treatment period.
Histopathological analysis confirmed the safety and effectiveness of Atriplex crassifolia extracts in reducing hyperglycemia.

Rehman et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

September 27, 2025PLoS ONEOpen Access

View Full Paper

Ask AI

Bookmark

Authors

Assessment finds Atriplex crassifolia extracts lower blood glucose levels in diabetic rats, suggesting their potential therapeutic role.

Atriplex crassifolia extracts significantly reduced blood glucose levels in an alloxan-induced diabetic model.
Key extracts, ACEA and ACNB, demonstrated notable hypoglycemic effects during oral glucose tolerance tests.
The study employed various doses to evaluate the extracts' effectiveness over a 28-day treatment period.
Histopathological analysis confirmed the safety and effectiveness of Atriplex crassifolia extracts in reducing hyperglycemia.

Rehman et al. (2025) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark